HJ Research delivers in-depth insights on the global Tuberculosis (TB) Diagnostics market in its upcoming report titled, Global Tuberculosis (TB) Diagnostics Market Report 2018-2029. According to this study, the global Tuberculosis (TB) Diagnostics market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Tuberculosis (TB) Diagnostics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Tuberculosis (TB) Diagnostics market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Tuberculosis (TB) Diagnostics industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Tuberculosis (TB) Diagnostics industry.
Global Tuberculosis (TB) Diagnostics market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Tuberculosis (TB) Diagnostics industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Tuberculosis (TB) Diagnostics market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Tuberculosis (TB) Diagnostics. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Tuberculosis (TB) Diagnostics market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Tuberculosis (TB) Diagnostics in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Tuberculosis (TB) Diagnostics market include:
Abbott
BD
bioMérieux
F. Hoffmann-La Roche
Thermo Fisher Scientific
Market segmentation, by product types:
Smear Microscopy
Molecular Testing
Mantoux Tuberculin Test
Culture
Drug Susceptibility Testing
LF-LAM for PLHIV
Market segmentation, by applications:
Diagnostic Laboratories
Hospitals
1 Industry Overview of Tuberculosis (TB) Diagnostics
1.1 Research Scope
1.2 Market Segmentation by Types of Tuberculosis (TB) Diagnostics
1.3 Market Segmentation by End Users of Tuberculosis (TB) Diagnostics
1.4 Market Dynamics Analysis of Tuberculosis (TB) Diagnostics
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Tuberculosis (TB) Diagnostics Industry
2.1 Abbott
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 BD
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 bioMérieux
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 F. Hoffmann-La Roche
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Thermo Fisher Scientific
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
3 Global Tuberculosis (TB) Diagnostics Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Tuberculosis (TB) Diagnostics by Regions (2018-2023)
3.2 Global Sales Revenue of Tuberculosis (TB) Diagnostics by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Tuberculosis (TB) Diagnostics by Types (2018-2023)
3.4 Global Sales Revenue of Tuberculosis (TB) Diagnostics by End Users (2018-2023)
4 Northern America Tuberculosis (TB) Diagnostics Market Analysis by Countries, Types and End Users
4.1 Northern America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
4.5 Canada Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5 Europe Tuberculosis (TB) Diagnostics Market Analysis by Countries, Types and End Users
5.1 Europe Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Tuberculosis (TB) Diagnostics Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.5 France Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.6 UK Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.7 Italy Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.8 Russia Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.9 Spain Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
5.10 Netherlands Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6 Asia Pacific Tuberculosis (TB) Diagnostics Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Tuberculosis (TB) Diagnostics Sales Revenue Analysis by End Users (2018-2023)
6.4 China Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.5 Japan Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.6 Korea Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.7 India Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.8 Australia Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.9 Indonesia Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
6.10 Vietnam Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
7 Latin America Tuberculosis (TB) Diagnostics Market Analysis by Countries, Types and End Users
7.1 Latin America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Tuberculosis (TB) Diagnostics Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
7.5 Mexico Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
7.6 Argentina Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
7.7 Colombia Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Tuberculosis (TB) Diagnostics Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Tuberculosis (TB) Diagnostics Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
8.6 South Africa Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
8.7 Egypt Tuberculosis (TB) Diagnostics Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Tuberculosis (TB) Diagnostics Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Tuberculosis (TB) Diagnostics by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Tuberculosis (TB) Diagnostics by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Tuberculosis (TB) Diagnostics by End Users (2024-2029)
10.4 Global Revenue Forecast of Tuberculosis (TB) Diagnostics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Tuberculosis (TB) Diagnostics
11.1 Upstream Analysis of Tuberculosis (TB) Diagnostics
11.2 Downstream Major Consumers Analysis of Tuberculosis (TB) Diagnostics
11.3 Major Suppliers of Tuberculosis (TB) Diagnostics with Contact Information
11.4 Supply Chain Relationship Analysis of Tuberculosis (TB) Diagnostics
12 Tuberculosis (TB) Diagnostics New Project Investment Feasibility Analysis
12.1 Tuberculosis (TB) Diagnostics New Project SWOT Analysis
12.2 Tuberculosis (TB) Diagnostics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Tuberculosis (TB) Diagnostics Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Tuberculosis (TB) Diagnostics
Table End Users of Tuberculosis (TB) Diagnostics
Figure Market Drivers Analysis of Tuberculosis (TB) Diagnostics
Figure Market Challenges Analysis of Tuberculosis (TB) Diagnostics
Figure Market Opportunities Analysis of Tuberculosis (TB) Diagnostics
Table Market Drivers Analysis of Tuberculosis (TB) Diagnostics
Table Abbott Information List
Figure Tuberculosis (TB) Diagnostics Specifications of Abbott
Table Tuberculosis (TB) Diagnostics Revenue (Million USD) and Gross Margin of Abbott (2018-2023)
Figure Tuberculosis (TB) Diagnostics Revenue (Million USD) and Global Market Share of Abbott (2018-2023)
Table BD Information List
Figure Tuberculosis (TB) Diagnostics Specifications of BD
Table Tuberculosis (TB) Diagnostics Revenue (Million USD) and Gross Margin of BD (2018-2023)
Figure Tuberculosis (TB) Diagnostics Revenue (Million USD) and Global Market Share of BD (2018-2023)
Table bioMérieux Information List
Figure Tuberculosis (TB) Diagnostics Specifications of bioMérieux
Table Tuberculosis (TB) Diagnostics Revenue (Million USD) and Gross Margin of bioMérieux (2018-2023)
Figure Tuberculosis (TB) Diagnostics Revenue (Million USD) and Global Market Share of bioMérieux (2018-2023)
Table F. Hoffmann-La Roche Information List
Figure Tuberculosis (TB) Diagnostics Specifications of F. Hoffmann-La Roche
Table Tuberculosis (TB) Diagnostics Revenue (Million USD) and Gross Margin of F. Hoffmann-La Roche (2018-2023)
Figure Tuberculosis (TB) Diagnostics Revenue (Million USD) and Global Market Share of F. Hoffmann-La Roche (2018-2023)
Table Thermo Fisher Scientific Information List
Figure Tuberculosis (TB) Diagnostics Specifications of Thermo Fisher Scientific
Table Tuberculosis (TB) Diagnostics Revenue (Million USD) and Gross Margin of Thermo Fisher Scientific (2018-2023)
Figure Tuberculosis (TB) Diagnostics Revenue (Million USD) and Global Market Share of Thermo Fisher Scientific (2018-2023)
Table Global Revenue (Million USD) of Tuberculosis (TB) Diagnostics by Regions (2018-2023)
Table Global Revenue (Million USD) of Tuberculosis (TB) Diagnostics by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Tuberculosis (TB) Diagnostics by Types (2018-2023)
Table Global Revenue (Million USD) of Tuberculosis (TB) Diagnostics by End Users (2018-2023)
Table Northern America Tuberculosis (TB) Diagnostics Revenue (Million USD) by Countries (2018-2023)
Table Northern America Tuberculosis (TB) Diagnostics Revenue (Million USD) by Types (2018-2023)
Table Northern America Tuberculosis (TB) Diagnostics Revenue (Million USD) by End Users (2018-2023)
Figure United States Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Tuberculosis (TB) Diagnostics Revenue (Million USD) by Countries (2018-2023)
Table Europe Tuberculosis (TB) Diagnostics Revenue (Million USD) by Types (2018-2023)
Table Europe Tuberculosis (TB) Diagnostics Revenue (Million USD) by End Users (2018-2023)
Figure Germany Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Tuberculosis (TB) Diagnostics Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Tuberculosis (TB) Diagnostics Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Tuberculosis (TB) Diagnostics Revenue (Million USD) by End Users (2018-2023)
Figure China Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Tuberculosis (TB) Diagnostics Revenue (Million USD) by Countries (2018-2023)
Table Latin America Tuberculosis (TB) Diagnostics Revenue (Million USD) by Types (2018-2023)
Table Latin America Tuberculosis (TB) Diagnostics Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Tuberculosis (TB) Diagnostics Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Tuberculosis (TB) Diagnostics Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Tuberculosis (TB) Diagnostics Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Tuberculosis (TB) Diagnostics Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Tuberculosis (TB) Diagnostics by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Tuberculosis (TB) Diagnostics by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Tuberculosis (TB) Diagnostics by End Users (2024-2029)
Table Major Consumers with Contact Information of Tuberculosis (TB) Diagnostics
Table Major Suppliers of Tuberculosis (TB) Diagnostics with Contact Information
Figure Supply Chain Relationship Analysis of Tuberculosis (TB) Diagnostics
Table New Project SWOT Analysis of Tuberculosis (TB) Diagnostics
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Tuberculosis (TB) Diagnostics
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Tuberculosis (TB) Diagnostics Industry
Table Part of References List of Tuberculosis (TB) Diagnostics Industry
Table Units of Measurement List
Table Part of Author Details List of Tuberculosis (TB) Diagnostics Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Tuberculosis (TB) Diagnostics industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Tuberculosis (TB) Diagnostics market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Tuberculosis (TB) Diagnostics manufacturers, Tuberculosis (TB) Diagnostics raw material suppliers, Tuberculosis (TB) Diagnostics distributors as well as buyers. The primary sources from the supply side include Tuberculosis (TB) Diagnostics manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Tuberculosis (TB) Diagnostics raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Tuberculosis (TB) Diagnostics industry landscape and trends, Tuberculosis (TB) Diagnostics market dynamics and key issues, Tuberculosis (TB) Diagnostics technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Tuberculosis (TB) Diagnostics competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Tuberculosis (TB) Diagnostics market size and forecast by regions, Tuberculosis (TB) Diagnostics market size and forecast by application, Tuberculosis (TB) Diagnostics market size and forecast by types, Tuberculosis (TB) Diagnostics company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
